The Computational Pathology Group develops, validates and deploys novel medical image analysis methods based on deep learning technology and focusing on computer-aided diagnosis. Application areas include diagnostics and prognostics of breast, prostate and colon cancer. We have rapidly expanded over the last few years, counting over 15 people today. Our group is among the international front runners in the field, witnessed for instance by our highly successful CAMELYON challenges. We have a strong translational focus, facilitated by our close collaboration with clinicians and industry.
Last month, Computational pathology group-members Francesco Ciompi and Jeroen van der Laak have been awarded 2 grants for performing cancer research based on deep learning techniques. Supported by funding of the European Union’s ICT12 H2020 program, Jeroen and Francesco will work together with a consortium of European partners on … Read more →
Peter Bandi and Oscar Geessink, organizers of CAMELYON17, challenged participants to move from individual metastases detection (CAMELYON16) to classification of lymph node status on a patient level. Over 300 participants registered on the challenge website, of which 23 teams submitted a total of 37 algorithms before the deadline. The algorithmic … Read more →
Joint project between DIAG and Fraunhofer MEVIS aimed at the development of a generic platform for automatic medical image analysis.
Read more →The goal of AQUILA is to investigate the prognostic value of Tumor Infiltrating Lymphocytes (TILs) in breast and colon cancer.
Read more →ISBI 2017 challenge to evaluate algorithms for automated detection and classification of breast cancer metastases in whole-slide images of histological lymph node sections.
Read more →The aim of this project is to use deep learning for histological assessment of the stroma for improved risk stratification of ductal carcinoma in situ (DCIS) patients.
Read more →In this project, we will combine deep learning and digitized whole-slide imaging of prostate cancer for reproducible extraction of quantitative biomarkers.
Read more →MULTIMOT aims to build an open data ecosystem for cell migration research, through standardization, dissemination and meta-analysis efforts.
Read more →Detecting biomarkers for improved prognosis for triple negative breast cancer by combining histopathology, multiplex immunohistochemistry and Deep Learning.
Read more →Project with focus on the extension of open-source software ASAP that includes functionality for study and case management.
Read more →The investigation of the role of immune cell subsets in interstitial fibrosis and tubular atrophy in renal allografts, using multiplex immunohistochemistry and Deep Learning.
Read more →We aim at developing automatic and reproducible quantification of Tumor-Stroma Ratio in Whole-Slide Images using Deep Learning.
Read more →In this project, we will develop and validate digital image analysis algorithms for quantification of tumor budding from scanned whole slide images.
Read more →
